Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. - Wikidata - awgldk - TriplyDB

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

http://www.wikidata.org/entity/Q33230301

about

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma Emerging treatment options for nasopharyngeal carcinoma Role of chemotherapy in nasopharyngeal carcinoma Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.Lack of influence of intravenous contrast on head and neck IMRT dose distributions.Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma.Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases.Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal.Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials Current management strategy of nasopharyngeal carcinoma.Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes.Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience.Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study.Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma.Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.A matched cohort study of standard chemo-radiotherapy versus radiotherapy alone in elderly nasopharyngeal carcinoma patients Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer.Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma.High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy

P2860

Q24200903-7218DA79-7F55-4BB9-8740-7D0D49E37C88 Q24243898-D644FF71-2F2D-46E5-92E9-5C62FCADB670 Q26995560-4EA2A370-1B61-4F48-B567-CB2B56024D71 Q27022454-07542E30-F1DC-4D72-B107-7E2B13DD1103 Q31064714-29BB62F2-F518-4B35-A8D9-0CEED017B637 Q33302524-3707497D-B5FA-4FED-B4EB-9964822AA115 Q33395652-ECDC2C11-7149-4368-A700-5471803B1947 Q33420052-F7EE5C0A-0A27-4D5A-980B-F8FBD8B3B951 Q33425830-A605FDF5-FBCB-4A0C-A90A-5FDA777E4628 Q33426763-61E2C347-1FB9-4D85-BA5C-4E4397DCB93F Q33428012-32F60AD4-5FD0-453D-9EFC-455E818C2A8C Q33433507-3E7C96D9-4C4B-4775-AE1A-7E5A7F457601 Q33530564-79B74FA9-0CCC-4F59-AFF8-DA9666E4D3D8 Q33573635-11AC6E22-987B-4D9A-AE51-4672F0041D2E Q33579396-B4D995A2-CB01-4E93-AD80-0A89042A13BC Q33602326-DCB4CC29-E61B-4889-A2BB-E8ED85B6F914 Q33702316-A7B0B730-F433-44B9-A7F4-66E451C08A01 Q33719825-5C362668-9788-49BE-A6AB-ADF7F7A0D01C Q33764579-D4F46E0E-B379-4D61-A17B-43EFE9B657AB Q33916098-7F95A84E-CC03-497B-8D07-084972506244 Q33994022-35ECF1A3-B8EF-425C-865F-BFD30274E97C Q34352211-88BE07CE-25BE-41AC-BDBD-3715E01FC879 Q34408305-096D300C-3E86-4B57-8EC3-E19FBAEF7998 Q34492567-E0B34FE8-EBE0-4E99-B754-29786CA611AF Q34662664-E99F9BC2-BE7B-47B7-B4B3-AED4D2A55F76 Q35030360-BF3262F3-3566-4328-AE3B-D843935D155C Q35103235-FCFCDC45-FC28-4A6F-9E8C-B0C912C8487C Q35108557-D934A749-FAF4-4B38-B23E-2F4D0FF05904 Q35117590-FBC9B9AE-901E-4907-8063-19DA2F81C3A7 Q35122866-F9B25672-D055-4C44-9F50-B18272EAC61B Q35144019-6BAD1D5C-91CF-4DEE-A313-C51062FF9BAB Q35154741-D5842573-33D8-4A0C-B4BC-3EB4906E9FFF Q35175736-B326D8B2-B72D-4DD0-A73D-57433F22DC93 Q35184996-0AB99F17-7B28-4751-A117-F4E710AF90A3 Q35507358-E6631CCE-ADD6-4A2B-933F-90B34E16C8EC Q35586691-E6BA41D0-C966-4EB2-A414-FCD6BEB71AE6 Q35591783-B4D51ECF-404B-40C7-8C01-341DC457913C Q35597559-51D04FC9-0938-4C83-8B7B-C8561A5941D2 Q35640038-DDEEF14A-6160-4F32-B549-DEBCA7D8FCCC Q35686424-72D50E7F-2741-418B-A7E4-0F79931B86C3

P2860

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

http://www.wikidata.org/entity/Q33230301

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Chemotherapy in locally advanc ...... ized trials and 1753 patients.

@ast

Chemotherapy in locally advanc ...... ized trials and 1753 patients.

@en

type

label

Chemotherapy in locally advanc ...... ized trials and 1753 patients.

@ast

Chemotherapy in locally advanc ...... ized trials and 1753 patients.

@en

prefLabel

Chemotherapy in locally advanc ...... ized trials and 1753 patients.

@ast

Chemotherapy in locally advanc ...... ized trials and 1753 patients.

@en

P1433

Q33230301-0949EE91-05F3-4495-9D76-5896A64C4B69

P1476

Q33230301-ECC6056B-F875-4C77-B404-3302BE27EED9

P2093

Q33230301-072A56EC-EE3B-4B96-9F57-687D101049B5

Q33230301-121EF5D2-DB54-4469-83B7-B5117D55F3BC

Q33230301-2B2BCE2B-3E3D-4DAE-BD04-7B386DEEA376

Q33230301-466728E5-22AD-4552-A800-A266618ADA51

Q33230301-A73EAE36-1112-4DF8-A940-2B9D8F1B6FE3

Q33230301-BE8F5BAC-385C-44F2-8E88-94D1A01B251F

Q33230301-C091C0E5-A764-4444-BC19-9488B12286FA

Q33230301-C1EA3699-A0D7-4919-AC49-359571AE2B5A

Q33230301-EE94F126-5252-4B3B-BAB3-B75EF31A4D4A

Q33230301-EF6E2E61-DBEA-49BD-AC66-3790117EEA76

P304

Q33230301-FE1222E2-EB4E-4467-9355-4EE2AA630DAD

P31

Q33230301-4174AD75-71DA-40AD-8F0E-22C5D1552F9F

Q33230301-f7dfde4e-c1ea-4326-8303-5970fa343fff

P356

Q33230301-3B355BC3-2515-4F6D-8185-67501E500756

P407

Q33230301-ABCD1108-C34F-4F7A-B9B4-C9E0A5B0CCF4

P433

Q33230301-0CB402BF-BD4D-4A22-8B70-AB9FD7C0BDE2

P478

Q33230301-6A4B334C-7B23-457F-B59D-8C15934964A7

P50

Q33230301-DB46E645-BE3B-413E-B3A7-8532DC39F375

Q33230301-E16D7D62-8348-470C-9173-1CDAB6925A1E

P577

Q33230301-2D409C2C-EABC-4B23-9E70-C60453FFD826

P5875

Q33230301-6F567DEA-7684-4576-A890-DA8DB8094687

P698

Q33230301-F5C370EE-6162-4CE1-AF1F-A8F7E6AFAED9

P921

Q33230301-844379AA-B6DA-4E2E-9258-EF1EEB5DB8EB

Q33230301-9C891CF9-EF52-4F7D-BC65-8A01F65FA39E

Q33230301-DD7EC820-2AA9-40CA-8990-073D1E23972F

P356

J.IJROBP.2005.06.037

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Chemotherapy in locally advanc ...... mized trials and 1753 patients

@en

P2093

Bertrand Baujat

http://www.w3.org/2001/XMLSchema#string

Daniel T T Chua

http://www.w3.org/2001/XMLSchema#string

Dora L W Kwong

http://www.w3.org/2001/XMLSchema#string

Haluk Onat

http://www.w3.org/2001/XMLSchema#string

Hélène Audry

http://www.w3.org/2001/XMLSchema#string

Jean Bourhis

http://www.w3.org/2001/XMLSchema#string

Kullathorn Thephamongkhol

http://www.w3.org/2001/XMLSchema#string

Kwan-Hwa Chi

http://www.w3.org/2001/XMLSchema#string

MAC-NPC Collaborative Group

http://www.w3.org/2001/XMLSchema#string

Masato Hareyama

http://www.w3.org/2001/XMLSchema#string

P304

47-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2005.06.037

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Pierre Pignon

Anthony Tak-Cheung Chan

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7394699

http://www.w3.org/2001/XMLSchema#string

P698

16377415

http://www.w3.org/2001/XMLSchema#string

P921